Facebook
Twitter
LinkedIn
Forward
June 3 CME Evaluation: Sleep, Sodium, and CVD - A Cardiology Perspective
Please follow the steps below for direct access to the evaluation for the June 3 CME Dinner "Sleep, Sodium, and CVD - A Cardiology Perspective"
IMPORTANT FIRST STEP
In order to access this evaluation form, you must first REGISTER or login on this website. To begin registration steps:
- Click on the Register/Take Course tab on this page and follow the instructions.
- Once the above step is complete you will be able to access the evaluation starting on Saturday, June 3 at 7:30pm EDT by clicking on the Register tab of this page. Please note this website will refer to this as a "Course", please disregard this. Once you are registered, you will have direct access to the evaluation survey to claim your credits.
The evaluation will be available on Saturday, June 3, 2023 at 7:30pm EDT. Evaluations must be completed by Monday, June 12, 2023 at 11:59 pm EDT. Upon completion of the CME/CE evaluation, attendees can download their certificate.
Target Audience
The educational design of this activity addresses the needs of U.S. based sleep specialists, psychiatrists, neurologists, pulmonologists, primary care physicians, nurses, nurse practitioners, physician assistants, pharmacists and allied healthcare professionals.
Learning Objectives
After completing this activity, the participant should be better able to:
- Summarize the data about the association of increased sodium intake and its impact on CVD risk and CVD outcomes.
- List current recommendations on daily sodium intake in adults with CVD or at-risk for CVD.
- Consider the full spectrum of CVD risk beyond hypertension when evaluating sodium intake, including in patients with sleep disorders, cardiovascular and cardiometabolic comorbidities, and those using medications high in sodium content.
- Develop practical strategies to minimize the impact of dietary and non-dietary sodium to reduce CVD risk.
Additional Information
| Attachment | Size |
|---|---|
 June 3 Presentation Slides | 6.92 MB |
Virend K. Somers, MD, PhD (Chair)
Professor of Medicine, Mayo Clinic
Rochester, MN
Lawrence J Appel, MD, MPH, FACP, FAHA
C. David Molina Professor of Medicine
Director, Welch Center for Prevention, Epidemiology and Clinical Research
Johns Hopkins University School of Medicine
Baltimore, MD
Richard K. Bogan, MD, FCCP, FAASM
Associate Clinical Professor
Medical University of South Carolina, Charleston, SC
University of South Carolina, Columbia, SC
Principal, Bogan Sleep Consultants, LLC
Deborah J. Clegg, PhD, RD
Vice President for Research
Professor, Internal Medicine
Texas Tech University Health Sciences Center
El Paso, TX
ACTIVITY TITLE
Sleep, Sodium, and CVD - A Cardiology Perspective
ACTIVITY DATE
June 3, 2023 at the JW Marriott Indianapolis | JW Grand Ballrooms 1-2
JOINT PROVIDERSHIP STATEMENT
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING EDUCATION
PACE designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.
PHARMACY CONTINUING EDUCATION
PACE designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA4008073-9999-23-148-L01-P. Type of activity: Application
FEE INFORMATION & REFUND/CANCELLATION POLICY
Registration to this event is complimentary, however you must be a registered attendee of the SLEEP 2023.
HOW TO REQUEST CE CREDIT
The evaluation link will be emailed to all attendees after the symposium. We will send the evaluation link using the email you entered in the iPads provided during the meeting. Upon completion of the CME/CE evaluation, you will be able to print your certificate.
Several email reminders will be sent post-meeting. Please claim your credits by completing the evaluation by Monday, June 12, 2023.
For Pharmacists: Please allow 2-3 weeks after the June 12 deadline for your credit to be submitted to the CPE Monitor. For questions regarding the evaluation, please contact: cmhc_eval@cardiometabolichealth.org
DISCLOSURES
Planners and Managers
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The CMHC planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Faculty
Dr. Appel has nothing to disclose.
Dr. Bogan discloses the following:
- Shareholder WaterMark Medical, Healthy Humming, LLC
- Board of Directors: WaterMark Medical
- Consultant to Jazz, Harmony Biosciences, Takeda, Avadel, Oventus
- Industry funded research for Avadel, BresoTec, Idorsia, Suven, Jazz, Balance, Vanda, Merck, Eisai, Philips, Fresca, Takeda, Liva Nova, Roche, Sommetrics, NLS, Sanofi, Apnimed
- Speakers Bureau for Jazz, Eisai, Harmony, Idorsia
Dr. Clegg has nothing to disclose.
Dr. Somers discloses the following:
- Advisor: Good Sleep
DISCLOSURE OF CONFLICT OF INTEREST
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Available Credit
- 1.50 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 Participation
The evaluation will be available on Saturday, June 3, 2023 at 7:30pm EDT. Evaluations must be completed by Monday, June 12, 2023 at 11:59 pm EDT. Upon completion of the CME/CE evaluation, attendees can download their certificate.
Required Hardware/software
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.